Companies: 48,687 Total Market Cap: 127308871272626.81

TMC Life Sciences Berhad

KLSE-TMCLIFE
Miscellaneous Health And Allied Services, Not Elsewhere Classified
Rank #19729
Market Cap 187.66 M
Volume 77,403.10
Price 0.11
Change (%) 3.16%
Country or region Malaysia Malaysia

TMC Life Sciences Berhad's latest marketcap:

187.66 M

As of May 3, 2025, TMC Life Sciences Berhad's market capitalization has reached $187.66 M. According to our data, TMC Life Sciences Berhad is the 19729th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 187.66 M
Revenue (ttm) 75.55 M
Net Income (ttm) 3.04 M
Shares Out 1.74 B
EPS (ttm) 0
Forward PE 0.00
Ex-Dividend Date December 5, 2024
Earnings Date May 23, 2025
Market Cap Chart
Data Updated: May 3, 2025

TMC Life Sciences Berhad's yearly market capitalization.

TMC Life Sciences Berhad has seen its market value drop from RM1.15 B to RM775.14 M since 2020, representing a total decrease of 32.58% and an annual compound decline rate (CAGR) of 8.73%.
Date Market Cap Change (%)
April 25, 2025 RM775.14 M -11%
December 31, 2024 RM870.94 M -30.07%
December 29, 2023 RM1.25 B 13.49%
December 30, 2022 RM1.10 B 18.87%
December 31, 2021 RM923.20 M -19.7%
December 31, 2020 RM1.15 B

Company Profile

About TMC Life Sciences Berhad

TMC Life Sciences Berhad is an investment holding company specializing in healthcare services across Malaysia. Established in 1994 and headquartered in Petaling Jaya, the company operates under its parent company, Sasteria (M) Pte. Ltd.

Core Healthcare Services

The company's flagship facility, Thomson Hospital Kota Damansara (THKD), is a leading medical center in Selangor offering specialized services, including:

  • Women and children's health
  • Cancer treatment
  • Orthopedics, ENT, and head & neck laser procedures
  • Gastroenterology, hepatology, and urology
  • Fertility and reproductive health services

Reproductive & Fertility Solutions

TMC Life Sciences provides advanced fertility treatments, such as:

  • In-vitro fertilisation (IVF)
  • Preimplantation genetic testing
  • Fertility preservation
  • Laparoscopic surgery and surgical sperm retrieval
  • Donation programs and consultancy services

Additional Offerings

  • Laboratory and embryology services
  • Traditional and complementary medicine
  • Pharmacy services and retail operations
  • Management support for multi-disciplinary tertiary care
  • Women's clinics and fertility centers

Other Activities

Beyond healthcare, the company engages in:

  • Research and development initiatives
  • Healthcare program development and management
  • Property investment ventures
Frequently Asked Questions

As of May 3, 2025, TMC Life Sciences Berhad (including the parent company, if applicable) has an estimated market capitalization of $187.66 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

TMC Life Sciences Berhad global market capitalization ranking is approximately 19729 as of May 3, 2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region Malaysia
Founded 1994
IPO Date n/a
Employees n/a
CEO Ahmad Bin Abdul Rahman
Sector
Industry Miscellaneous Health And Allied Services, Not Elsewhere Classified
Address No. 11, Jalan Teknologi
Petaling Jaya, 47810
Malaysia
People Also Watch
SGX-5G3
0.34 3.16%
BOM-526783
50.70 3.16%
SGXC-40T
0.27 3.16%
EGX-AMES
0.44 3.16%